TREATMENT OF REDUCING THE SIGNS AND SYMPTOMS / TREATMENT OF THE SIGNS AND SYMPTOMS / TREATMENT OF PROSTATE CANCER / TREATMENT OF HIV / TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA / TREATMENT OF MAJOR DEPRESSIVE DISORDER / /
MedicalCondition
PAIN / WITH EPILEPSY / CANCER / WITH CHRONIC LYMPHOCYTIC LEUKEMIA / FOR CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES / IDIOPATHIC (IMMUNE) THROMBOCYTOPENIC PURPURA / HUNTINGTON'S DISEASE / OF A DISEASE / OF MAJOR DEPRESSIVE DISORDER / OF OVERACTIVE BLADDER / METASTATIC PHEOCHROMOCYTOMAS / /
CDER New Molecular Entity (NME) Drug and New Biologic Approvals for Calendar Year 2008 Updated through December 31, 2008 NME New Drug Application (NDA) Approvals: Application Type